Skip to main content
 logo

Search form

  • Licensing
    • Licensing Opportunities
    • License Research Materials
    • Featured Technologies
    • License Notices/Reports
    • Licensing Process
    • NIH Start-Up Exclusive License Agreements
    • Non-Profit License Agreement - Summary
  • Policy
    • CRADAs
    • FOIA
    • HHS TT Policies
    • Policies & Reports
    • Useful Links
  • Royalty
    • Contact your Royalty Coordinator
    • Information for Licensees
    • Information for NIH Inventors
    • Payment Center
  • Outreach
    • License Research Materials
    • Product Pipeline
    • Product Showcase
    • RSS Feed
  • Resources
  • Reports/Stats
    • Annual Reports
    • Technology Transfer Statistics
    • Technology Transfer Metrics
    • Presentations & Articles
    • Top 20 Commercially Successful Inventions
    • Videos
    • HHS-Licensed Products Approved by the FDA
    • Business Opportunities at the NIH
    • Chen Lecture Videos
    • Stories of Discovery
  • FAQs
    • Licensing
    • Patent Legal Services
    • Royalties
    • CRADA & MTA FAQs
  • About OTT
    • Contact us
    • Organization Chart
    • Staff Directory
    • Management
    • Location and Directions
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer

You are here

Home

All Inventions from Dr. Noel Southall

  • Heterocyclic Compounds for the Treatment of Hepatitis C Virus
  •    Ref: E-161-2014-0 | Updated: Aug 24, 2018 | NIDDK
  • Glucocerebrosidase Non-inhibitory Chaperones for the Treatment of Gaucher Disease, Parkinson's Disease, and...
  •    Ref: E-144-2012-0 | Updated: May 1, 2018 | NHGRI
  • Novel Dopamine D2 Receptor Antagonists and Methods of Their Use
  •    Ref: E-030-2013-0 | Updated: Sep 5, 2017 | NCATS
  • Novel Small Molecule Agonists of the Relaxin Receptor as Potential Therapy for Heart Failure and Fibrosis
  •    Ref: E-072-2012-0 | Updated: Nov 18, 2015 | NCATS
  • Novel Small Molecule Antimalarials for Elimination of Malaria Transmission
  •    Ref: E-751-2013-0 | Updated: Nov 18, 2015 | NCATS
  • New Targeted Therapy for Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
  •    Ref: E-060-2011-0 | Updated: Sep 10, 2012 | NHGRI
  • Methods of Treating Giardiasis Using FDA-Approved Compounds
  •    Ref: E-211-2010-1 | Updated: Aug 17, 2012 | NCATS
  • Glucocerebrosidase Activators as a Treatment for Gaucher Disease
  •    Ref: E-257-2010-0 | Updated: Oct 6, 2011 | NCATS
  • Novel Small Molecule Inhibitors for the Treatment of Huntington’s Disease
  •    Ref: E-258-2010-0 | Updated: Jun 8, 2011 | NCATS

    Displaying 1 - 9 of 9

    Category Index

    Find Technologies

    To find any text within the description of the invention.
    Any part of the E#. e.g. entering "123" will search for E-123-1012, E-123-2013, etc.

    Help

    Utility Links

    • Open data
    • Privacy Notice
    • Web Policies and Notices
    • Accessibility
    • NIH
    • HHS
    • For NIH Staff Only

    Office of Technology Transfer, Office of Intramural Research, National Institutes of Health

    6011 Executive Blvd, Suite 325, Rockville, MD 20852 | Phone: 301-496-7057

    • Partnerships
      • Partnerships

        These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

        • Opportunities
        • Process
        • Startups
        • Non-Profits
        • Fees
        • Business Opportunities
        • Product Showcase
        • Product Pipeline

        The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

         

    • Inventing
      • Inventing

        These links provide access to information that is needed for NIH inventors regarding past or present research.

        • Royalties
        • Research Submission
        • Collaboration

        Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

         

    • Reports
      • Reports

        These links provide access to reports tracking the success of NIH licensed products.

        • Annual Reports
        • Statistics & Metrics
        • Commercial Outcomes

        The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

         

    • Resources
      • Resources

        These links provide resources to those interested in the technology transfer activities at NIH.

        • Video Library
        • Presentations & Articles
        • RSS Feeds

        Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

         

    • Policy & Regulations
      • Policies & Regulations

        These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

        • Freedom of Information Act (FOIA)
        • HHS Technology Transfer Policy
        • Policies & Reports
        • Useful Links

        If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

         

    • About
      • About Us

        These links provide information about the Office of Technology Transfer.

        • Contact Us
        • Staff Directory
        • HHS Tech Transfer Offices & Contacts
        • FAQs

        The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.